BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 26036189)

  • 1. Doppler Ultrasound Flow Evaluation of the Uterine Arteries Significantly Correlates with Tumor Size in Cervical Cancer Patients.
    Bolla D; In-Albon S; Papadia A; Di Naro E; Gasparri ML; Mueller MM; Raio L
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S959-63. PubMed ID: 26036189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Transvaginal color-Doppler sonography for monitoring the response to neoadjuvant chemotherapy in patients with locally advanced cervical cancer].
    Di Vagno G; Cormio G; Vimercati A; Nacci G; Greco P; Lepera A; Loverro G; Selvaggi L
    Minerva Ginecol; 1996 Nov; 48(11):463-7. PubMed ID: 9005372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Three-Dimensional Power Doppler Ultrasound for Predicting Response and Local Recurrence After Concomitant Chemoradiation Therapy for Locally Advanced Carcinoma of the Cervix.
    Alcazar JL; Arribas S; Martinez-Monge R; Jurado M
    Int J Gynecol Cancer; 2016 Mar; 26(3):534-8. PubMed ID: 26745701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Power Doppler angiographic appearance and blood flow velocity waveforms in invasive cervical carcinoma.
    Wu YC; Yuan CC; Hung JH; Chao KC; Yen MS; Ng HT
    Gynecol Oncol; 2000 Nov; 79(2):181-6. PubMed ID: 11063641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PRospective Imaging of CErvical cancer and neoadjuvant treatment (PRICE) study: role of ultrasound to predict partial response in locally advanced cervical cancer patients undergoing chemoradiation and radical surgery.
    Testa AC; Ferrandina G; Moro F; Pasciuto T; Moruzzi MC; De Blasis I; Mascilini F; Foti E; Autorino R; Collarino A; Gui B; Zannoni GF; Gambacorta MA; Valentini AL; Rufini V; Scambia G
    Ultrasound Obstet Gynecol; 2018 May; 51(5):684-695. PubMed ID: 28620930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PRospective Imaging of CErvical cancer and neoadjuvant treatment (PRICE) study: role of ultrasound to assess residual tumor in locally advanced cervical cancer patients undergoing chemoradiation and radical surgery.
    Testa AC; Moro F; Pasciuto T; Moruzzi MC; Di Legge A; Fuoco G; Autorino R; Collarino A; Gui B; Zannoni GF; Gambacorta A; Miccò M; Rufini V; Scambia G; Ferrandina G
    Ultrasound Obstet Gynecol; 2018 Jul; 52(1):110-118. PubMed ID: 29119649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transvaginal color Doppler for predicting pathological response to preoperative chemoradiation in locally advanced cervical carcinoma: a preliminary study.
    Alcázar JL; Jurado M
    Ultrasound Med Biol; 1999 Sep; 25(7):1041-5. PubMed ID: 10574335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transvaginal color Doppler ultrasound for monitoring the response to neoadjuvant chemotherapy in advanced cervical cancer.
    Greco P; Cormio G; Vimercati A; Nacci G; di Vagno G; Loverro G; Selvaggi L
    Acta Obstet Gynecol Scand; 1997 Feb; 76(2):169-72. PubMed ID: 9049292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transrectal ultrasound and magnetic resonance imaging in the evaluation of tumor size following neoadjuvant chemotherapy for locally advanced cervical cancer.
    Pinkavova I; Fischerova D; Zikan M; Burgetova A; Slama J; Svarovsky J; Dundr P; Dusek L; Cibula D
    Ultrasound Obstet Gynecol; 2013 Dec; 42(6):705-12. PubMed ID: 23495185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive value of diffusion-weighted magnetic resonance imaging during chemoradiotherapy for uterine cervical cancer.
    Makino H; Kato H; Furui T; Morishige K; Kanematsu M
    J Obstet Gynaecol Res; 2014 Apr; 40(4):1098-104. PubMed ID: 24320754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Value of three-dimensional power Doppler to predict clinical and histological response to neoadjuvant chemotherapy in locally advanced cervical carcinoma.
    Qin J; Cheng X; Chen X; Zhang X; Lu W; Xie X
    Ultrasound Obstet Gynecol; 2012 Feb; 39(2):226-34. PubMed ID: 21845741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sonographic characteristics of squamous cell cancer and adenocarcinoma of the uterine cervix.
    Epstein E; Di Legge A; Måsbäck A; Lindqvist PG; Kannisto P; Testa AC
    Ultrasound Obstet Gynecol; 2010 Oct; 36(4):512-6. PubMed ID: 20336641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparison of uterine artery chemoembolization and internal iliac arterial infusion chemotherapy for the combining treatment for women with locally advanced cervical cancer].
    Yu L; Tan GS; Xiang XH; Guo WB; Li HP; Huang YH; Yang JY
    Ai Zheng; 2009 Apr; 28(4):402-7. PubMed ID: 19622301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Laparoscopic lymph node dissection should be performed before fertility preserving treatment of patients with cervical cancer.
    Vercellino GF; Piek JM; Schneider A; Köhler C; Mangler M; Speiser D; Chiantera V
    Gynecol Oncol; 2012 Sep; 126(3):325-9. PubMed ID: 22704949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor vascularization in cervical cancer by 3-dimensional power Doppler angiography: correlation with tumor characteristics.
    Alcázar JL; Jurado M; López-García G
    Int J Gynecol Cancer; 2010 Apr; 20(3):393-7. PubMed ID: 20375803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Three-dimensional power Doppler ultrasound in cervical carcinoma: monitoring treatment response to radiotherapy.
    Huang YF; Cheng YM; Wu YP; Chen HH; Hsu KF; Wu YH; Chou CY
    Ultrasound Obstet Gynecol; 2013 Jul; 42(1):84-92. PubMed ID: 22744872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of serum VEGFA, TIMP2, MMP2 and MMP9 in monitoring response to adjuvant radiochemotherapy in patients with primary cervical cancer--results of a companion protocol of the randomized NOGGO-AGO phase III clinical trial.
    Braicu EI; Gasimli K; Richter R; Nassir M; Kümmel S; Blohmer JU; Yalcinkaya I; Chekerov R; Ignat I; Ionescu A; Mentze M; Fotopoulou C; Pop C; Lichtenegger W; Sehouli J; ;
    Anticancer Res; 2014 Jan; 34(1):385-91. PubMed ID: 24403492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neoadjuvant chemotherapy followed by large cone resection as fertility-sparing therapy in stage IB cervical cancer.
    Salihi R; Leunen K; Van Limbergen E; Moerman P; Neven P; Vergote I
    Gynecol Oncol; 2015 Dec; 139(3):447-51. PubMed ID: 26050921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of cervical volume and spectral Doppler parameters in tumour dominant vessel of patients with locally advanced squamous cell cervical carcinoma.
    Tomalczyk A; Tomasik B; Fijuth J; Moszynska-Zielinska M; Gottwald L
    J Obstet Gynaecol; 2021 Oct; 41(7):1116-1120. PubMed ID: 33427547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neoadjuvant chemotherapy followed by robotic radical hysterectomy in locally advanced cervical cancer: a multi-institution study.
    Vizza E; Corrado G; Zanagnolo V; Tomaselli T; Cutillo G; Mancini E; Maggioni A
    Gynecol Oncol; 2014 May; 133(2):180-5. PubMed ID: 24589412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.